HK1257587A1 - 預防和治療肝纖維化的藥物及其用途 - Google Patents

預防和治療肝纖維化的藥物及其用途

Info

Publication number
HK1257587A1
HK1257587A1 HK18116706.1A HK18116706A HK1257587A1 HK 1257587 A1 HK1257587 A1 HK 1257587A1 HK 18116706 A HK18116706 A HK 18116706A HK 1257587 A1 HK1257587 A1 HK 1257587A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
liver fibrosis
treating liver
treating
Prior art date
Application number
HK18116706.1A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257587A1 publication Critical patent/HK1257587A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116706.1A 2016-12-15 2018-12-28 預防和治療肝纖維化的藥物及其用途 HK1257587A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611162270 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257587A1 true HK1257587A1 (zh) 2019-10-25

Family

ID=62656674

Family Applications (5)

Application Number Title Priority Date Filing Date
HK18116708.9A HK1257589A1 (zh) 2016-12-15 2018-12-28 預防和治療組織器官纖維化的藥物及其用途
HK18116707.0A HK1257588A1 (zh) 2016-12-15 2018-12-28 預防和治療肺纖維化的藥物及其用途
HK18116703.4A HK1257584A1 (zh) 2016-12-15 2018-12-28 預防和治療系統性硬化症的藥物及其用途
HK18116704.3A HK1257585A1 (zh) 2016-12-15 2018-12-28 預防和治療皮膚纖維化的藥物及其用途
HK18116706.1A HK1257587A1 (zh) 2016-12-15 2018-12-28 預防和治療肝纖維化的藥物及其用途

Family Applications Before (4)

Application Number Title Priority Date Filing Date
HK18116708.9A HK1257589A1 (zh) 2016-12-15 2018-12-28 預防和治療組織器官纖維化的藥物及其用途
HK18116707.0A HK1257588A1 (zh) 2016-12-15 2018-12-28 預防和治療肺纖維化的藥物及其用途
HK18116703.4A HK1257584A1 (zh) 2016-12-15 2018-12-28 預防和治療系統性硬化症的藥物及其用途
HK18116704.3A HK1257585A1 (zh) 2016-12-15 2018-12-28 預防和治療皮膚纖維化的藥物及其用途

Country Status (2)

Country Link
CN (5) CN108210910A (zh)
HK (5) HK1257589A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917335B (zh) * 2018-09-20 2023-06-27 华中科技大学同济医学院附属同济医院 Erdr1在预防和治疗纤维化疾病中的用途
US20230084586A1 (en) * 2020-02-06 2023-03-16 Talengen International Limited Method and drug for preventing and treating multiple sclerosis
CN115551534A (zh) * 2020-02-26 2022-12-30 泰伦基国际有限公司 一种预防和治疗血压异常病症的方法和药物
CN113925022A (zh) * 2021-10-22 2022-01-14 莫汉有 一种系统性红斑狼疮并动脉粥样硬化动物模型构建方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00011713A (es) * 2000-11-28 2002-05-31 Tgt Lab S A De C V Vectores recombinantes virales y no virales conteniendo el gen humano del activador de plasminogeno derivado de urocinasa y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar, pancreatica, cardiaca y cicatrices hipe
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US20050250694A1 (en) * 2003-10-10 2005-11-10 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
AU2008331545B2 (en) * 2007-11-29 2014-01-16 Grifols Therapeutics Inc. Recombinantly modified plasmin
CN102482338B (zh) * 2009-07-10 2016-09-28 斯路姆基因公司 纤溶酶原和纤溶酶的变体
CN101628113B (zh) * 2009-08-18 2012-01-04 南京农业大学 蚯蚓纤溶酶抗肝纤维化的应用
US20120114652A1 (en) * 2010-05-03 2012-05-10 Abbott Laboratories Anti-pai-1 antibodies and methods of use thereof
WO2013134781A1 (en) * 2012-03-09 2013-09-12 Vascular Biosciences Orally active, cell-penetrating homing peptide and methods of using same
KR101467109B1 (ko) * 2013-07-10 2014-12-01 영남대학교 산학협력단 Ｂｉｘ02189 화합물을 유효성분으로 포함하는 폐섬유증 예방 또는 치료용 조성물
CN112142845A (zh) * 2013-08-13 2020-12-29 赛诺菲 纤溶酶原激活剂抑制剂-1(pai-1)的抗体及其用途
TW201722994A (zh) * 2013-08-13 2017-07-01 賽諾菲公司 胞漿素原活化素抑制劑-１（ｐａｉ-１）之抗體及其用途
US20160199466A1 (en) * 2013-08-20 2016-07-14 Trustees Of Dartmouth College Methods For Treating Tissue Fibrosis

Also Published As

Publication number Publication date
HK1257589A1 (zh) 2019-10-25
CN108210905A (zh) 2018-06-29
CN108210910A (zh) 2018-06-29
HK1257588A1 (zh) 2019-10-25
HK1257585A1 (zh) 2019-10-25
CN108210892A (zh) 2018-06-29
HK1257584A1 (zh) 2019-10-25
CN108210899A (zh) 2018-06-29
CN108210897A (zh) 2018-06-29

Similar Documents

Publication Publication Date Title
HK1258396A1 (zh) 用於治療纖維化的賽尼克韋羅聯合療法
IL271025A (en) Multibiotic substances and methods of using them
IL261444A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
HK1258276A1 (zh) 用於治療hiv的化合物和組合
HK1259545A1 (zh) 用於治療癌症的bcl-2抑制劑和mek抑制劑組合產品
IL265955A (en) Therapeutic compounds and methods of use thereof
HK1257587A1 (zh) 預防和治療肝纖維化的藥物及其用途
IL275182A (en) Preparations and methods for the treatment of metabolic conditions
HK1257237A1 (zh) 預防和治療脂肪肝的藥物及其用途
GB201617064D0 (en) Compounds and their therapeutic use
IL266486A (en) Pharmaceutical preparations and methods for cancer treatment
ZA201804380B (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
ZA201900984B (en) Methods and compositions for the treatment of warts
HK1255695A1 (zh) 用於治療眼瞼下垂的組合物和方法
HK1257586A1 (zh) 預防和治療腎纖維化的藥物及其用途
IL266726A (en) Therapies for the treatment of lidocaine-ineffective and hypokalemic conditions
HK1257238A1 (zh) 預防和治療脂質腎損傷的藥物及其用途
ZA201706985B (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
IL265242B (en) Compounds for the treatment of hypertension and/or fibrosis
PL3327201T3 (pl) Pojemnik i jego zastosowanie
ZA201706986B (en) Compositions for the treatment of kidney and/or liver disease
EP3490604C0 (en) MEDICATION FOR THE TREATMENT AND/OR PREVENTION OF ENDOMETRIOSIS
HUE050096T2 (hu) Vegyület alkalmazásra neurodegeneratív betegségek megelõzésére és kezelésére
ZA202004110B (en) Compositions and methods for the treatment of metabolic conditions
HK1255631A1 (zh) 用於預防和治療睡眠障礙的藥物組合物